Full article: Australian access to FDA approved breakthrough therapy designation medicines: a 10 year review Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia Therapeutic Innovation & Regulatory Science Springer Nature Link A health warning about unregulated peptides has been issued by Australia's drug regulator but doctors say more action is needed. Reporting by national health equity reporters Caitlyn Gribbin and Rachel Carbonell, ABC IGF 1 LR3 Superior Peptide Human Growth Hormone Injection IGF 1 LR3 Injection from New Delhi Safety advisory Understanding your responsibilities when importing, compounding and supplying unapproved peptide products We are concerned about the rise in the import, supply, compounding and advertising of unapproved peptide products